Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 6:48 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1825–1848 of 121,474 matching trials from the live ClinicalTrials.gov search.

Filters: Completed Clear all

Conditions: Solid Cancers
Interventions: Grape Seed Extract, Vitamin D; Drug
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Heart Defects, Congenital, Hyperglycemia
Interventions: Insulin, Usual Care; Drug · Other
Lead sponsor: Boston Children's Hospital; Other
Eligibility: Up to 36 Months
Enrollment: 989 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2014
U.S. locations: 2
States / cities: Boston, Massachusetts • Ann Arbor, Michigan

Conditions: Breast Cancer, Psychosocial Effects of Cancer and Its Treatment
Interventions: counseling intervention, educational intervention, psychosocial assessment and care; Behavioral · Other · Procedure
Lead sponsor: Georgetown University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 331 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2011
U.S. locations: 4
States / cities: Washington D.C., District of Columbia • Chevy Chase, Maryland • Hackensack, New Jersey + 1 more

Conditions: Healthy
Interventions: ALXN1840, Omeprazole; Drug
Lead sponsor: Alexion Pharmaceuticals, Inc.; Industry
Eligibility: 19 Years to 55 Years
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014
U.S. locations: 1
States / cities: Lincoln, Nebraska

Conditions: Traumatic Brain Injury
Interventions: Teen Online Problem Solving (TOPS), Teen Online Problem Solving--Teen Only (TOPS-TO), Internet Resources Comparison (IRC); Behavioral
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 11 Years to 18 Years
Enrollment: 153 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 5
States / cities: Denver, Colorado • Cincinnati, Ohio • Cleveland, Ohio + 1 more

Conditions: Asthma, Bronchospasm, Shortness of Breath
Interventions: Virtual Teach to Goal, Brief Intervention; Behavioral
Lead sponsor: University of Chicago; Other
Eligibility: 5 Years to 10 Years
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Nephrotic Syndrome, Proteinuria
Interventions: apixaban; Drug
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 79 Years
Enrollment: 21 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Phenylketonuria, PKU
Interventions: RDD to Palynziq; Drug
Lead sponsor: BioMarin Pharmaceutical; Industry
Eligibility: 18 Years and older
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Chevy Chase, Maryland

Conditions: Gestational Diabetes Mellitus
Interventions: Standard Protocol for intrapartum glucose management, Experimental Protocol for intrapartum glucose management; Other
Lead sponsor: Women and Infants Hospital of Rhode Island; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 76 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Healthy Volunteers
Interventions: 3 mg PF-03882845, 10 mg PF-03882845, 30 mg PF-03882845, 100 mg PF-03882845, Spironolactone; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Migraine
Interventions: Mindfulness Based Stress Reduction, Migraine/stress Education; Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 89 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Leukemia, Myelodysplastic Syndrome
Interventions: Clofarabine with Busulfan; Drug
Lead sponsor: Baylor Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Platelet Activation Testing Before/After Anti-platelet Therapy, Healthy
Interventions: Aspirin, Clopidogrel; Drug
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 112 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Contraception, Menorrhagia
Interventions: ESS305 (Essure, BAY1454032), NovaSure; Device · Procedure
Lead sponsor: Bayer; Industry
Eligibility: 21 Years to 50 Years · Female only
Enrollment: 211 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2021
U.S. locations: 17
States / cities: Aurora, Colorado • Ocala, Florida • Decatur, Illinois + 14 more

Conditions: Sarcoma, Kaposi, HIV Infections
Interventions: Interferon alfa-2a, Zidovudine; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 12 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Ends 1993
U.S. locations: 9
States / cities: Miami, Florida • Baltimore, Maryland • Boston, Massachusetts + 6 more

Conditions: Bladder Cancer, Cervical Cancer, Esophageal Cancer, Gastric Cancer, Head and Neck Cancer, Kidney Cancer, Leukemia, Liver Cancer, Lung Cancer, Pancreatic Cancer, Tobacco Use Disorder
Interventions: zinc oxide; Dietary Supplement
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 21 Years to 120 Years
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2015
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: SARS-CoV Infection
Interventions: COVID-19 vaccine; Biological
Lead sponsor: National Jewish Health; Other
Eligibility: 18 Years and older
Enrollment: 360 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Pregnancy
Interventions: Not listed
Lead sponsor: Prisma Health-Upstate; Other
Eligibility: Female only
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Greenville, South Carolina

Conditions: Urothelial Carcinoma
Interventions: MV-NIS; Biological
Lead sponsor: Vyriad, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 3
States / cities: Miami, Florida • New Orleans, Louisiana • Rochester, Minnesota

Conditions: Urinalysis
Interventions: Testing of self collected urine, Labeling Evaluation, Urine Control testing; Device
Lead sponsor: Ascensia Diabetes Care; Industry
Eligibility: 18 Years and older
Enrollment: 126 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Epilepsy
Interventions: Keppra XR (Levetiracetam XR); Drug
Lead sponsor: UCB Pharma; Industry
Eligibility: 12 Years to 75 Years
Enrollment: 190 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 16
States / cities: Dothan, Alabama • Northport, Alabama • Phoenix, Arizona + 13 more

Conditions: Epilepsy
Interventions: Not listed
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2001
U.S. locations: 1
States / cities: New Hyde Park, New York

Conditions: Food Selection, Obesity, Weight Gain, Food Preferences
Interventions: Intervention "Standard"; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: Not listed
Enrollment: 101,481 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: CYP2D6 Polymorphism
Interventions: Isotretinoin, dextromethorphan; Drug
Lead sponsor: University of Washington; Other
Eligibility: 12 Years and older
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2023
U.S. locations: 1
States / cities: Seattle, Washington

Search by objective public record fields.

Phase I Assay-guided Trial of Anti-inflammatory Phytochemicals in Patients With Advanced Cancer

SPECS: Safe Pediatric Euglycemia in Cardiac Surgery

Genetic Counseling or Usual Care in Helping Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I, Stage II, or Stage IIIA Breast Cancer Make Treatment Decisions

A Study of ALXN1840 (Non-coated) Administered With And Without Omeprazole In Healthy Adults

Rehabilitation Research and Training Center for Traumatic Brain Injury Interventions--Teen Online Problem Solving Study

Virtual Teach-to-Goal Education vs. Brief Education for Children

Pharmacokinetics of Apixaban in Nephrotic Syndrome

Rapid Drug Desensitization Study in Adults Experiencing Hypersensitivity Reactions to Palynziq

Intrapartum Glucose Management Among Women With Gestational Diabetes Mellitus

A Single Dose Study Of Antimineralocorticoid Activity Of PF-03882845 In Healthy Volunteers

Mindfulness and Mechanisms of Pain Processing in Adults With Migraines

Study of Stem Cell Transplant for Leukemia and Myelodysplastic Syndromes Using Clofarabine and Busulfan Regimen

The Accuracy Of A Novel Platelet Activity Assay In Humans On Antiplatelet Agents: Pharmacodynamics And Comparison With Light Transmission Aggregometry

A Study to Evaluate the Effectiveness of Essure Post-NovaSure Radiofrequency Endometrial Ablation Procedure Following a Successful Essure Confirmation Test

Phase II Study of Zidovudine and Recombinant Alpha-2A Interferon in the Treatment of Patients With AIDS-Associated Kaposi's Sarcoma

Zinc Supplements in Lowering Cadmium Levels in Smokers

COVID-19 Vaccine Response in Chronic Respiratory Conditions

Outpatient Cervical Ripening

Trial of Intravesical Measles Virotherapy in Patients With Bladder Cancer Who Are Undergoing Radical Cystectomy

Ketostix® and Keto-Diastix® Performance Study

Long Term Follow-up Study With Keppra XR (Levetiracetam XR) for Partial Seizures

Observational Study of Lamotrigine

Changing Portion Size Descriptions in a Cafeteria

Effects of Isotretinoin on CYP2D6 Activity